-
First New PTSD Drug in Two Decades On the Horizon?
15 Jul 2025 08:03 GMT
The Psychopharmacologic Drugs Advisory Committee … consider a supplemental new drug application for brexpiprazole (Rexulti … As with any new drug application, several questions … , Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, …
-
Ovarian Cancer Drugs Market to Hit $7.2 Billion by 2035, Driven by Rising FDA Approvals and 2024's $4.2 Billion Base
14 Jul 2025 07:02 GMT
… Lilly and Co., and Pfizer Inc., among others. The … .
• Novartis Pharma AG
• Pfizer Inc.
• Sanofi-aventis Australia … Analysis
Global Ovarian Cancer Drugs Market by Drug Class
• PARP … L1 Inhibitors
Global Ovarian Cancer Drugs Market by Therapy
• …
-
Pfizer, Sanofi Find Relief As Delaware Top Court Rejects Zantac Expert Testimony
11 Jul 2025 13:08 GMT
… heartburn drug, has been sold at different times by companies, including Pfizer … submitted expert reports linking the drug to ten types of cancer … to proceed.
In May 2024, Pfizer settled 10,000 lawsuits alleging …
-
Top 10 Cancer Drugs Market Set to Skyrocket to Nearly $200 Billion by 2032 Amid Global Cancer Surge
11 Jul 2025 07:58 GMT
… ; Co., Inc.
Novartis AG
Pfizer Inc.
Key Benefits for Stakeholders … identify potential top 10 cancer drugs market opportunities in genetics.
• … the body. The cancer drug market is expected to … cost associated with new drug development and side effects …
-
Functional Dyspepsia Market Analysis And Forecast, 2025-2035, Competitive Analysis Of Astrazeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong
11 Jul 2025 09:39 GMT
… Major players include AstraZeneca and Pfizer, highlighting a competitive landscape … symptom trackers, and targeted drug delivery are transforming disease management … helping companies identify opportunities for drug and technology development. Organizations …
-
Burns Market Analysis And Forecast Report 2025-2035 Featuring Pfizer, Perrigo, Kenvue Brands, 3M, Smith+Nephew, Molnlycke, Cardinal Health, Convatec, Haleon, Coloplast, Deroyal Industries
11 Jul 2025 09:39 GMT
(MENAFN- GlobeNewsWire - Nasdaq) The global burns market is experiencing significant growth, fueled by rising burn incidences and enhanced awareness of wound care. Increased occurrences of road accidents and industrial mishaps have propelled the demand for …
-
Dangers of a drug sector monopoly
11 Jul 2025 05:00 GMT
… on non-prescription drugs is 35%; prescription drugs, 30%; and … while advertising third-schedule drugs (requiring a doctor … global firms Roche, Bayer, Pfizer, and GlaxoSmithKline.
While CDAP … demand for cheaper generic drugs, potentially decreasing the demand …
-
Pfizer & Astellas Pharma announces positive results from phase 3 EMBARK study of Xtandi plus leuprolide in men with non-metastatic hormone-sensitive prostate cancer with BCR
11 Jul 2025 04:33 GMT
… oncology chief development officer, Pfizer. “These positive results add … exemplify Astellas’ and Pfizer’s longstanding commitment to … continuous creation of new drugs to address diseases … including small molecules, antibody-drug conjugates (ADCs), and …
-
Dementia warning as drug taken by millions raises risk of memory robbing disorder by up to 40%, study finds
11 Jul 2025 02:54 GMT
… prove that taking the drug will cause dementia—merely … blame.
The drug—manufactured by pharmaceutical giant Pfizer of Covid vaccine … times.
The drug, manufactured by pharmaceutical giant Pfizer, acts on … mechanism of how the drug could be influencing dementia …
-
AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma
10 Jul 2025 23:42 GMT
… edge over currently available bispecific drugs for multiple myeloma. Johnson … on cancer cells. Meanwhile, Pfizer’s Elrexfio binds to CD38 … and BCMA-targeting bispecific drug awarded FDA approval last … of an approved drug. The IGI drug represents the second …
About
© 1995-2025